Manufacturer of Controlled Substances; Notice of Application, 18001 [E8-6775]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 64 / Wednesday, April 2, 2008 / Notices
controlled substance listed in schedule
II.
The company plans to import the
listed controlled substance for the
manufacture of a bulk controlled
substance for distribution to its
customer.
As noted in a previous notice
published in the Federal Register on
September 23, 1975, (40 FR 43745), all
applicants for registration to import a
basic class of any controlled substances
in schedule I or II are, and will continue
to be, required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: March 27, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–6774 Filed 4–1–08; 8:45 am]
Control, Federal Register Representative
(ODL), Washington, DC 20537, or any
being sent via express mail should be
sent to Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than June 2, 2008.
ADDRESSES:
Dated: March 27, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–6775 Filed 4–1–08; 8:45 am]
I. Background
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employee Benefits Security
Administration
Proposed Extension of Information
Collection Request Submitted for
Public Comment; Consent To Receive
Employee Benefit Plan Disclosure
Electronically
BILLING CODE 4410–09–P
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice.
AGENCY:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on March 4, 2008,
Lonza Riverside, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Schedule
rmajette on PROD1PC64 with NOTICES
Gamma
hydroxybutyric
acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
I
II
II
The company plans to manufacture
bulk products for finished dosage units
and distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR § 1301.33(a).
Any such written comments or
objections being sent via regular mail
should be addressed, in quintuplicate,
to the Drug Enforcement
Administration, Office of Diversion
VerDate Aug<31>2005
15:36 Apr 01, 2008
Jkt 214001
18001
SUMMARY: The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and Federal agencies with an
opportunity to comment on proposed
and continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995 (PRA
95). This program helps to ensure that
requested data can be provided in the
desired format, reporting burden (time
and financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employee Benefits Security
Administration is soliciting comments
on the proposed extension of an
information collection request (ICR)
incorporated in the Final Rules relating
to the use of electronic communication
and recordkeeping technologies by
employee pension and welfare benefit
plans (29 CFR 2520.104b–1).
A copy of the information collection
request (ICR) can be obtained by
contacting the individual shown in the
ADDRESSES section of this notice or at
https://www.RegInfo.gov.
DATES: Written comments must be
submitted to the office shown in the
ADDRESSES section on or before June 2,
2008.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
G. Christopher Cosby,
Department of Labor, Employee Benefits
Security Administration, 200
Constitution Avenue NW., Washington,
DC 20210, (202) 693–8410, FAX (202)
693–4745 (these are not toll-free
numbers).
SUPPLEMENTARY INFORMATION:
The Department established a safe
harbor pursuant to which all pension
and welfare benefit plans covered by
Title I of ERISA may use electronic
media to satisfy disclosure obligations
under Title I of ERISA (29 CFR
2520.104b–1). Employee benefit plan
administrators will be deemed to satisfy
their disclosure obligations when
furnishing documents electronically
only if a participant who does not have
access to the employer’s electronic
information system in the normal course
of his duties, or a beneficiary or other
person entitled to documents, has
affirmatively consented to receive
disclosure documents. Prior to
consenting, the participant or
beneficiary must also be provided with
a clear and conspicuous statement
indicating the types of documents to
which the consent would apply, that
consent may be withdrawn at any time,
procedures for withdrawing consent and
updating necessary information, the
right to obtain a paper copy, and any
hardware and software requirements. In
the event of a hardware or software
change that creates a material risk that
the individual will be unable to access
or retain documents that were the
subject of the initial consent, the
individual must be provided with
information concerning the revised
hardware or software, and an
opportunity to withdraw a prior
consent.
II. Review Focus
The Department of Labor
(Department) is particularly interested
in comments that:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 73, Number 64 (Wednesday, April 2, 2008)]
[Notices]
[Page 18001]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-6775]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on March 4, 2008, Lonza
Riverside, 900 River Road, Conshohocken, Pennsylvania 19428, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma hydroxybutyric acid (2010)........... I
Amphetamine (1100)......................... II
Methylphenidate (1724)..................... II
------------------------------------------------------------------------
The company plans to manufacture bulk products for finished dosage
units and distribution to its customers.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR Sec. 1301.33(a).
Any such written comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537, or any being sent via
express mail should be sent to Drug Enforcement Administration, Office
of Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than June 2, 2008.
Dated: March 27, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-6775 Filed 4-1-08; 8:45 am]
BILLING CODE 4410-09-P
